Discovery Knows No Bounds

Discovery knows no bounds

© Copyright 2019 Regenerative Medicine Minnesota

Pluripotent stem cells

Treating cancer using the patient's immune system

Research Grant Recipient: Bruce Walcheck, PhD

Grant Period: 2015-2017

Award Value: $500,000

Site: University of Minnesota

Explore

Quantifying the DNA Damage Response in Clinical Grade Pluripotent Stem Cells

Biobusiness grant recipient: Matt Nelson, PhD

Grant Period: 2015-2016

Site: ReGen Theranostics, Inc.

Click here to read Nelson's Final Report

Quantifying the DNA Damage Response in Clinical Grade Pluripotent Stem Cells; An Efficient, Highly Sensitive Means of Establishing a Quality Control Standard in Large Scale Pluripotent Stem Cell Production

Explore

Manufacturing Cell Therapies using Induced Pluripotent Stem Cells in Minnesota

Biobusiness Grant Recipient: James R. Dutton, PhD

Grant Period: 2015-2016

Site: Stem Cell Institute | University of Minnesota

Click here to read Dutton's Final Report

For years, embryonic stem (ES) cells have shown great promise in helping to stimulate our body’s own ability to heal, but there are limitations to using these cells. Oftentimes, ES cells are rejected by the body’s immune system because they are not native to the body. There is another type of stem cell, though, that lack these compatibility issues.

Explore